Nanomedicine and drug delivery systems
Nanomedicine uses nanoscale materials to diagnose, monitor and treat disease. Drug delivery systems built from nanoparticles can carry medicines to specific cells, protect fragile drugs and release them at the right time, improving results and reducing side effects.
The Nanomedicine and drug delivery systems session at GCMN 2027 brings together materials scientists, pharmacists and clinicians. It connects closely with biomaterials and bioinspired materials, which supply many of the carriers and scaffolds used in treatment.
Key Topics in Nanomedicine and drug delivery systems
• Lipid nanoparticles and liposomes
• Polymeric and inorganic nanocarriers
• Targeted and stimuli-responsive drug delivery
• Nanoparticles for imaging and diagnostics
• Theranostics
• Nucleic acid and vaccine delivery
• Crossing biological barriers
• Nanotoxicology and biocompatibility
• Scale-up and manufacturing of nanomedicines
• Clinical translation and regulatory pathways
Recent Advances in Nanomedicine and drug delivery systems
Lipid nanoparticles became widely known through mRNA vaccines and are now being used for gene therapies and new vaccines. Researchers are designing carriers that release drugs only in response to signals such as acidity or enzymes found in diseased tissue.
DNA-based and protein-based carriers from bio nanotechnology and synthetic biology are adding new options, while magnetic nanoparticles from magnetic materials and spintronic technologies support targeted heating and imaging. Safety and approval remain key challenges, linking this field with ethics, safety, and regulations in nanotechnology.
Who Should Attend the Nanomedicine and drug delivery systems Session
• Nanomedicine and pharmaceutical scientists
• Biomedical engineers and drug delivery researchers
• Clinicians and clinical researchers
• Pharmaceutical and biotech R&D teams
• PhD students and postdoctoral researchers
• Regulatory affairs professionals
Why Present Your Research in Nanomedicine and drug delivery systems
Presenting at GCMN 2027 puts your nanomedicine research in front of an audience that spans materials, biology and medicine. You can share results and connect with colleagues in nanotechnology and nanomaterials developing the next generation of carriers.
Submit Your Abstract – Nanomedicine and drug delivery systems Session
We welcome laboratory, preclinical and clinical studies, as well as reviews, on nanomedicine and drug delivery. Choose an oral, poster or e-poster presentation, in person or online.
Submit your abstract for GCMN 2027 →
Frequently Asked Questions
Can I submit preclinical animal studies?
Yes. Preclinical studies with clear methods and ethical approval are welcome.
Does this session include diagnostic nanoparticles?
Yes. Nanoparticles for imaging, diagnosis and theranostics fit this session.
When and where is GCMN 2027?
GCMN 2027 takes place from 4 to 6 March 2027 at Village Hotel Changi, Singapore, and online.